Angiogenesis plays a significant role in tumor development, while the VEGF signaling is an important regulator of angiogenesis11,12, therefore, targeting angiogenesis by inhibition of VEGF and or VEGFR is a potential treatment option for many cancers. This evidence concerns the gene KDR and neoplasm.